340binformed.org - Your Free Source for 340B News and Commentary

Seventh Drug Company Told It is Violating 340B Law

Print ArticleOct. 12, 2021– Eight drug companies have restricted access to discounts to safety-net providers through the 340B drug pricing program on drugs dispensed at community-based pharmacies. Now the government officially has informed all but one of those companies that they are in violation of federal law and must restore the discounted pricing. The most […]

HHS Takes Vital Next Step Toward Ending 340B Pricing Denials

Print ArticleOct. 1, 2021– The federal government has taken dramatic action to get drug companies to restore 340B pricing for outpatient prescription drugs dispensed by community pharmacies to patients of 340B hospitals. On Sept. 22, the Health Resources & Services Administration (HRSA) sent letters to six drugmakers informing them that the agency is asking the […]

Diabetes Care Bears the Brunt of Drugmakers’ 340B Restrictions

Sept. 23, 2021– The eight pharmaceutical companies that are restricting the discounts they offer through the 340B drug pricing program are blocking safety-net hospitals’ access to savings on a wide range of prescription drugs. But perhaps in no area … [Read More...]

Report by Anti-340B Group Presents Erroneous Picture

Sept. 14, 2021– A new report issued by the Community Oncology Alliance (COA) claims 340B hospitals “charge both commercial payers and uninsured patients extraordinarily high prices and use an aggressive form of price discrimination between … [Read More...]

Momentum Grows to End Medicare Cuts for 340B Hospitals

Sept. 9, 2021– Calls are increasing for the Biden administration to stop deep Medicare Part B payment cuts to many hospitals participating in the 340B drug pricing program. The reductions, which have been in place since January 2018, have been … [Read More...]

Merck Plan to Withhold 340B Discounts Adds to Threat to Diabetes Patients

August 26, 2021 - The global pharmaceutical manufacturer Merck is the latest company to announce it will stop offering 340B discounts to hospitals on drugs dispensed to patients at community pharmacies. The move comes three months after the federal … [Read More...]

Hope and Vigilance in the 340B Community

By Maureen Testoni August 9, 2021– From my perspective, last month’s 340B Coalition Summer Conference was notable for several reasons. The first was that it marked the 25th year of hosting the conference, reflecting on a quarter-century of work … [Read More...]

Bipartisan Congressional Calls to Protect 340B Intensify

Aug. 4, 2021– A pair of lawmakers is working to advance the latest example of bipartisan, pro-340B legislation in Congress. Reps. Abigail Spanberger (D-Va.) and David McKinley (R-W.V.) recently introduced the Preserving Rules Ordered for The Entities … [Read More...]

Federal Report Suggests Another Reason To End 340B Orphan Drug Loophole